The burgeoning global dosage cups market, projected to reach US$2.3 billion by 2023 and with an estimated CAGR of 5.0% through 2023 to 2033, reflects a surging need for precise drug measurement tools. The market’s anticipated expansion to a valuation of US$3.7 billion by 2033 underscores the pivotal role these cups play in healthcare. The demand surge is driven by the imperative for dependable and accurate medication administration instruments.
Top 5 companies are poised to secure a quarter of the market share in 2023, fostering heightened competition and innovation. Notably, the above 35ml dosage cups segment is set to dominate the market due to its capacity benefits. The reusable dosage cups’ projected incremental opportunity of US$1.0 billion signifies the market’s adaptability to eco-friendly solutions.
The impending absolute growth opportunity of US$1.5 billion, propelled by diverse end-use sectors, underscores the paramount importance of precise drug dosing. In the critical realm of disease management, errors in medication dosage could yield severe repercussions, underscoring the vital role of pharmaceutical measuring equipment like dosage cups in enhancing patient safety and therapeutic efficacy.
Request a report sample to gain comprehensive insights: https://www.futuremarketinsights.com/reports/sample/rep-gb-13441
The sale of over-the-counter drugs is rising across the world, as a result, it will fuel the demand for dosage cups. Disposable cups are offered in both disposable and reusable types. Currently, reusable dosage cups segment dominates the global market. However, FMI predicts sales of disposable dosage cups to pick up pace due to their ability to lower the risk of contamination.
Reusable dosage cups can be used several times while taking medications and are highly accurate in their measurements, which helps to increase demand for medicine measuring cups among different end-users. The disposable dosage cups on the other hand are single-use cups and can be thrown away after use, which is not harmful to the environment.
Dosage cups are created to ensure safe individual dosages and ease of use for elderly children who have difficulty swallowing tablets and capsules. Hence, surge in geriatric population will continue to boost dosage cup sales over the next ten years.
Similarly, increasing need for convenience during medicine intake and growing awareness among people of the benefits of taking a fixed dose of medication using dosage cups will drive the market swiftly during the assessment period.
Key Takeaways from Dosage Cups Market
- Based on capacity, the above 35ml segment is estimated to hold around 43.8% value share of the global dosage cups market in 2023.
- By product type, the reusable dosage cups segment is anticipated to expand 2.7 times the current market value during the projection period.
- In terms of end users, the pharmaceutical segment is projected to expand at 5.7% CAGR during the forecast period.
- North America is expected to remain the most dominant market for dosage cups during the forecast period.
- The USA is forecast to hold around 12.7% share of the global dosage cups industry in 2033.
- China is set to hold a prominent share of 10.6% in the global dosage cups market by the end of 2033.
“Increasing popularity of dosage cups as reliable medicine measuring tools along with innovation in packaging designs is expected to boost the global dosage cups market. Besides this, introduction of new eco-friendly dosage cups will create lucrative opportunities for manufacturers,” says an FMI analyst.
Rising Presence of Clinical Labs across the World to Fuel Market Expansion
The growing cases of infectious diseases and other health issues across the world will support the expansion of dosage cups in the clinical laboratory. People are more aware of regular blood check-ups and concerned about their health which is a key factor driving the global dosage cups market forward.
Dosage cups provide error-free measurement which is beneficial for taking blood and other samples. As a result, dosage cups are preferred by clinical laboratories, ultimately increasing demand in the market.
Expansion of diagnostics labs and rising geriatric population across the world will supplement sales of dosage cups as these cups are more functional for the geriatric population and clinical labs.
The dosage cups also have the benefit of having undergone comprehensive stability testing before being delivered to the end user as the final package. The patient is then handed the packaged product in its final form, unaltered by a pharmacist or anybody else. This guarantees that the product’s integrity—unaltered from production to patient is maintained.
Key Drivers
- Growing demand for cost-effectiveness and convenient drug measuring devices and rising sales of over-the-counter drugs across the globe are driving the market.
- The adoption of printed dosage cups is increasing across clinical labs and hospitals because they offer greater accuracy in drug delivery.
Key Restraints
- Stringent regulations implemented on the manufacturing of plastics products across North America and Asia Pacific are hampering the growth of the dosage cups market.
- Availability of more precise and reusable dosage measuring devices such as droppers, syringes, and cylindrical spoons are hindering the sales of dosage cups.
Competitive Landscape
As per FMI, the top player operating in the dosage cups market are Sonoco Products Company, Gerresheimer AG, Medline Industries, Inc., Comar LLC, SGH Healthcaring, H&T Presspart Manufacturing Ltd., Hammarplast Medical AB, and Origin Pharma Packaging. These companies are expected to account nearly 20% to 25% share in the global landscape.
Leading players are focusing on launching new products and increasing their production capacity to cater the increasing demand for dosage cups. Some of the players are aiming at expanding their global footprint by merger & acquisitions with local players. For instance,
- In July 2021, H&T Manufacturing Ltd., a leading manufacturer of drug-delivery systems and pharmaceutical components, announced acquiring Novelex AG, a pharmaceuticals plastic components and devices manufacturer, to expand its product portfolio and global footprint.
- In January 2020, LLC Farmmash, a manufacturer of polymer closures and dose measuring, announced launching its new dosing cup SD-15. The dosing cup ranges from 20 ml to 25 ml and can be equipped with a child resistance cap. The strategy will assist the company to increase their market share.
Request Report Methodology: https://www.futuremarketinsights.com/askus/rep-gb-13441
Market Segmentation:
By Capacity:
- Upto 15ml
- 16ml to 35ml
- Above 35ml
By Product Type:
- Reusable
- Disposable
By Printing:
- Printed
- Non-printed
- Embossed
By End-Users:
- Hospitals
- Clinical Labs
- Medical Institutions
- Households
- Pharmaceuticals
- Others
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
Contact:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
